No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr14:103821000-103825200 |
Enhancers |
NHEK |
skin
|
2 |
chr14:103822400-103826800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
3 |
chr14:103822600-103827000 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
4 |
chr14:103822600-103828200 |
Weak transcription |
A549 |
lung
|
5 |
chr14:103822800-103828200 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
6 |
chr14:103822800-103828200 |
Weak transcription |
Dnd41 |
blood
|
7 |
chr14:103823000-103827600 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
8 |
chr14:103823000-103827800 |
Weak transcription |
Primary monocytes fromperipheralblood |
blood
|
9 |
chr14:103823600-103826400 |
Weak transcription |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
10 |
chr14:103823800-103826600 |
Weak transcription |
HepG2 |
liver
|
11 |
chr14:103823800-103827000 |
Weak transcription |
Hela-S3 |
cervix
|
12 |
chr14:103823800-103828000 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
13 |
chr14:103824200-103824800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
14 |
chr14:103824200-103825000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
15 |
chr14:103824200-103825200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
16 |
chr14:103824200-103825200 |
Enhancers |
HMEC |
breast
|
17 |
chr14:103824400-103825000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
18 |
chr14:103824400-103826200 |
Weak transcription |
K562 |
blood
|
19 |
chr14:103824400-103827800 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
20 |
chr14:103824600-103824800 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
21 |
chr14:103824600-103827800 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|